Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study

Background/Aims Fecal S100A12 (FS) and serum S100A12 (SS) have been reported as novel biomarkers that accurately reflect intestinal inflammation. We evaluated if FS and SS in comparison to fecal calprotectin (FC) are associated with poor future outcomes in clinically quiescent Crohn’s disease (CD) p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Association for the Study of Intestinal Diseases 2022-04-01
coleção:	Intestinal Research
Assuntos:	s100a12 protein calprotectin crohn disease
Acesso em linha:	http://www.irjournal.org/upload/pdf/ir-2021-00020.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!